CryoLife, Inc. (CRY) Social Stream
Cryolife Inc (CRY) Price Targets From Analysts
Use the tables below to see what analysts covering Cryolife Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 39 weeks, CRY's average price target has gone up $1.52.
Over the past 50 weeks, CRY's average upside potential has been 30.23%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CRY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 61 days, CRY's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRY as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Cryolife Inc's number of analysts covering the stock is higher than 24.96% of them.
- Cryolife Inc's average analyst price target is greater than 143.35% of stocks in the small market cap category.
- In terms of how Cryolife Inc fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -25.25% of that group.
- In terms of how Cryolife Inc fares relative to Medical Equipment stocks, note that its upside potential (average analyst target price relative to current price) is higher than 122.93% of that group.
What is the outlook for CRY? Use POWR Ratings for clearer insight into price direction.